Page URL: https://www.bionews.org.uk/page_89166

California group seeks stem cell funds

11 February 2004
By BioNews
Appeared in BioNews 245

A campaign has begun in the US state of California to include a bill in the November ballot to facilitate funding for embryonic stem cell (ES cell) research by establishing a three billion dollar bond. The bill is seen as a 'counter' to the stem cell policies of President George W Bush and the campaign group - made up of patient advocate groups and scientific researchers - want the bond to provide 295 million dollars of state funding per year to Californian universities, research institutes and companies involved in research into ES cells. It also wants to allocate funding for cloning projects to create stem cells for regenerative therapies, but specifies that cloning for reproductive purposes is not to be allowed.

The group, which calls itself 'Californians for Stem Cell Research and Cures', stipulates that the funds should only be available to those researchers who use ES cells derived from human embryos that are less than two weeks old. It also proposes that a 29-member panel be established, appointed by state governor Arnold Schwarzenegger, chancellors of the University of California and other officials, to distribute the funds in the form of grants. The group needs to raise 20 million dollars to promote their proposal and says that it has so far raised 2.5 million of these. It also needs to get supporting signatures of 600,000 Californian voters by 16 April this year in order to be able to qualify for the November ballot. If it does and, in November, the proposal is approved, California will be the first US state to fund ES cell research.

On 9 August 2001, President Bush announced that ES cell research supported by federal funds could only take place on stem cell lines that were already in existence at that time. Research that would cause the destruction of any further embryos for research would not be permitted. The US National Institutes of Health (NIH) identified 78 existing ES cell lines at the time, of which 12 are available to scientists. But US researchers have since complained that the ES cell lines available for them are not as good as later-produced lines, which were created using newer techniques, in particular without the use of mouse 'feeder' cells.

In September 2002, in what was seen as a direct challenge to the policy of the Bush administration, the state government of California approved legislation allowing ES cell work to take place in the state, and this was supported by the then state governor, Gray Davis. In December 2002, three more US states announced plans to consider measures to permit ES cell research and therapeutic cloning, despite the fact that the federal government still had not managed to complete its debates or vote on the issue. Similar bills were later introduced in Pennsylvania, New Jersey and Massachusetts, with New Jersey becoming the second state assembly to legislate specifically for the promotion of ES cell research in January this year.

SOURCES & REFERENCES
Californians want stem cell studies to get going
Chicago Sun-Times |  8 February 2004
Group seeks state funds for stem cell research
San Diego Union Tribune |  7 February 2004
Stem cell research backers push for funding measure
Contra Costa Times |  7 February 2004
Stem cell research sought
San Jose Mercury News |  7 February 2004
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
4 November 2004 - by BioNews 
Voters in the US state of California have passed Proposition 71, a bill also known as the California Stem Cell Research and Cures Initiative. Fifty-nine per cent of people voted in favour, with 41 per cent voting against the measure, which will establish California as the first state to publicly...
20 October 2004 - by BioNews 
Arnold Schwarzenegger, the Republican governor of California, has formally endorsed a bill that, if passed, would provide $3 billion of funding for embryonic stem (ES) cell research in the state over the next ten years. The bill, known as proposition 71, or the California Stem Cell Research and Cures Initiative...
16 August 2004 - by BioNews 
Voters in California are said to be 'evenly divided' over a bill that would provide the state with $3 billion of funding for human embryonic stem (ES) cell research. Known as Proposition 71, or the California Stem Cell Research and Cures Initiative, the bill will be part of the 2...
9 August 2004 - by BioNews 
The Californian Republican Party has voted at its annual convention to oppose a bill that would provide the state with $3 billion dollars for embryonic stem (ES) cell research. The California Research and Cures Initiative, which began in February, is backed by the group Californians for Stem Cell Research and...
7 June 2004 - by BioNews 
A bond proposal organised by the group Californians for Stem Cell Research and Cures (CSCRC) in order to facilitate state funding for embryonic stem (ES) cell research, has qualified for ballot on 2 November. The campaign, which began in February, aimed to establish a three billion dollar bond. The campaign...
12 January 2004 - by BioNews 
The legislature of the US state of New Jersey has taken major steps towards allowing embryo stem (ES) cell research. In December, the state assembly passed a bill by 41-31 specifically promoting ES cell research - making it only the second state in the US to do so. Last week...
9 December 2002 - by BioNews 
Three more American states have announced plans to consider measures next year that would permit embryonic stem cell (ES cell) research and therapeutic cloning, despite the fact that the federal government has not yet finished debating the issue. President Bush is known to favour a federal ban on all forms...
23 September 2002 - by BioNews 
Gray Davis, the Governor of California, US, has signed a bill that allows state-funded human embryonic stem cell (ES cell) research to take place in the state. The move is a direct challenge to the policy of the Bush administration, and is expected to attract scientists to California who wish...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.